Skip to content

ATB THERAPEUTICS: what changed

BE 0677.980.015NACE 21.100, Manufacture of basic pharmaceutical products and pharmaceutical preparationsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€8.0m
2024 · -€3.3m-€4.7m
Equity
€5.1m
2024 · €13.1m-€8.0m
Cash
€1.9m
2024 · €13.5m-€11.6m
Balance sheet total
€10.6m
2024 · €14.0m-€3.4m

Largest movements

2024 to 2025
Assets
  • Cash -€11.6m

    down €11.6m (-86.2%), from €13.5m to €1.9m

    mainly Net result for the year (-€8.0m) and Current investments (-€7.5m)

  • Current investments +€7.5m

    first reported in 2025, at €7.5m

  • Tangible fixed assets +€570,242

    up €570,242 (+898%), from €63,476 to €633,717

    of which Leasing and similar rights: +€376,536

  • Receivables after one year +€190,688

    up €190,688 (+86.3%), from €221,001 to €411,689

Equity and liabilities
  • Profit (loss) carried forward -€8.0m

    down €8.0m (-106%), from -€7.5m to -€15.5m

  • Other debts +€3.0m

    up €3.0m, from €0 to €3.0m

  • Trade debts +€852,384

    up €852,384 (+112%), from €758,989 to €1.6m

  • Tax, wage and social debts +€365,666

    up €365,666 (+252%), from €145,164 to €510,830

    of which Remuneration and social security: +€365,666

  • Debts after one year +€246,911

    up €246,911 (+945%), from €26,130 to €273,040

Income statement
  • Depreciation +€4.4m

    up €4.4m (+326%), from €1.4m to €5.8m

  • Purchases and services -€2.3m

    no longer reported in 2025; in 2024 it stood at €2.3m

  • Staff costs +€1.1m

    up €1.1m (+140%), from €783,826 to €1.9m

  • Gross operating margin +€371,855

    up €371,855 (+42.0%), from -€885,092 to -€513,236

  • Financial charges -€271,888

    down €271,888 (-91.1%), from €298,520 to €26,631

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€3.3m
Gross operating margin +€371,855
Staff costs -€1.1m
Depreciation -€4.4m
Other operating charges -€8,222
Financial income +€50,006
Financial charges +€271,888
Taxes +€144,732
Result 2025 -€8.0m
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€1.8m
Investment -€13.8m
Financing +€353,360
Cash 2024 €13.5m
Net result for the year -€8.0m
Depreciation +€5.8m
Receivables after one year -€190,688
Receivables within one year -€34,112
Deferred charges and accrued income +€399
Trade debts +€852,384
Tax, wage and social debts +€365,666
Other debts +€3.0m
Investment in fixed assets (net) -€6.4m
Current investments -€7.5m
Debts after one year +€246,911
Current portion of long-term debt +€106,449
Cash 2025 €1.9m
brings cash intakes cash out
Every line side by side 53 lines
Line Code 2024 2025 Change %
Total assets 20/58 €14,033,155 €10,639,520 -€3.4m -24.2%
Formation expenses 20 €0 €0 =
Fixed assets 21/28 €84,512 €657,339 +€572,827 +678%
Intangible fixed assets 21 €0 €0 =
Tangible fixed assets 22/27 €63,476 €633,717 +€570,242 +898%
Plant, machinery and equipment 23 €10,991 €135,544 +€124,553 +1,133%
Furniture and vehicles 24 €4,581 €73,734 +€69,153 +1,510%
Leasing and similar rights 25 €47,903 €424,439 +€376,536 +786%
Financial fixed assets 28 €21,037 €23,622 +€2,585 +12.3%
Current assets 29/58 €13,948,643 €9,982,181 -€4.0m -28.4%
Amounts receivable after more than one year 29 €221,001 €411,689 +€190,688 +86.3%
Other amounts receivable 291 €221,001 €411,689 +€190,688 +86.3%
Amounts receivable within one year 40/41 €192,886 €226,998 +€34,112 +17.7%
Trade receivables 40 €20,134 €0 -€20,134 -100%
Other amounts receivable 41 €172,753 €226,998 +€54,245 +31.4%
Current investments 50/53 - €7,450,000 +€7.5m
Cash at bank and in hand 54/58 €13,500,259 €1,859,396 -€11.6m -86.2%
Deferred charges and accrued income 490/1 €34,497 €34,098 -€399 -1.2%
Total equity and liabilities 10/49 €14,033,155 €10,639,520 -€3.4m -24.2%
Equity 10/15 €13,077,656 €5,081,751 -€8.0m -61.1%
Contributions 10/11 €20,613,696 €20,613,696 = 0.0%
Capital 10 €20,613,696 €20,613,696 = 0.0%
Issued capital 100 €20,613,696 €20,613,696 = 0.0%
Profit (loss) carried forward 14 -€7,536,039 -€15,531,944 -€8.0m -106%
Investment grants 15 €0 €0 =
Amounts payable 17/49 €955,499 €5,557,769 +€4.6m +482%
Amounts payable after more than one year 17 €26,130 €273,040 +€246,911 +945%
Financial debts 170/4 €26,130 €273,040 +€246,911 +945%
Amounts payable within one year 42/48 €929,369 €5,284,728 +€4.4m +469%
Current portion of amounts payable after more than one year 42 €25,216 €131,665 +€106,449 +422%
Financial debts 43 €0 - =
Credit institutions 430/8 €0 - =
Trade debts 44 €758,989 €1,611,373 +€852,384 +112%
Suppliers 440/4 €758,989 €1,611,373 +€852,384 +112%
Taxes, remuneration and social security 45 €145,164 €510,830 +€365,666 +252%
Taxes 450/3 €600 €600 = 0.0%
Remuneration and social security 454/9 €144,564 €510,230 +€365,666 +253%
Other amounts payable 47/48 €0 €3,030,860 +€3.0m
Accrued charges and deferred income 492/3 €0 - =
Goods, raw materials, services and sundry goods 60/61 €2,340,876 - -€2.3m
Remuneration, social security and pensions 62 €783,826 €1,884,571 +€1.1m +140%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,363,020 €5,800,475 +€4.4m +326%
Other operating charges 640/8 €3,610 €11,832 +€8,222 +228%
Gross operating margin 9900 -€885,092 -€513,236 +€371,855 +42.0%
Operating profit (loss) 9901 -€3,035,548 -€8,210,115 -€5.2m -170%
Financial income 75/76B €146 €50,153 +€50,006 +34,204%
Recurring financial income 75 €146 €50,153 +€50,006 +34,204%
Financial charges 65/66B €298,520 €26,631 -€271,888 -91.1%
Recurring financial charges 65 €298,520 €26,631 -€271,888 -91.1%
Profit (loss) for the period before taxes 9903 -€3,333,922 -€8,186,593 -€4.9m -146%
Income taxes 67/77 -€45,956 -€190,688 -€144,732 -315%
Profit (loss) for the period 9904 -€3,287,966 -€7,995,905 -€4.7m -143%
Profit (loss) for the period to be appropriated 9905 -€3,287,966 -€7,995,905 -€4.7m -143%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€5.1m to €5.1m

Midpoint €5.1m · adjusted equity only

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €5.1m
Indication €5.1m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€5,081,751
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€5.1m

Capitalised earnings

net result for the year (9904)
2025
-€7,995,905
2024
-€3,287,966
2023
-€2,127,736
2022
-€1,350,862
2021
-€1,200,182
Average result
-€4,470,535
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.